{"docId":"AFP_ENG_20101009.0147","headline":"German firm shelves libido-boosting drug for women","named_entity":{"FDA":[[2,"ORGANIZATION",31,31],[7,"ORGANIZATION",2,2],[9,"ORGANIZATION",7,7]],"United States":[[6,"LOCATION",25,26]],"Europe":[[6,"LOCATION",22,22]],"German":[[1,"MISC",1,1],[2,"MISC",1,1]],"Boehringer":[[3,"PERSON",41,41]],"Canada":[[6,"LOCATION",20,20]],"Boehringer Ingelheim":[[2,"ORGANIZATION",4,5],[11,"PERSON",1,2],[14,"PERSON",1,2]],"US Reproductive Health Drugs Advisory Committee":[[10,"ORGANIZATION",2,7]],"Andreas Barner":[[15,"PERSON",19,20]],"US Food and Drug Administration":[[2,"ORGANIZATION",25,29]],"US":[[7,"LOCATION",8,8]]},"cluster_json":[[{"sent_ind":4,"word":"women","mention_type":"NOMINAL","token_ind":30,"end_ind":31},{"sent_ind":12,"word":"women","mention_type":"NOMINAL","token_ind":9,"end_ind":10},{"sent_ind":6,"word":"women","mention_type":"NOMINAL","token_ind":16,"end_ind":17},{"sent_ind":1,"word":"women","mention_type":"NOMINAL","token_ind":7,"end_ind":8},{"sent_ind":4,"word":"their","mention_type":"PRONOMINAL","token_ind":41,"end_ind":42}],[{"sent_ind":9,"word":"the FDA","mention_type":"PROPER","token_ind":6,"end_ind":8},{"sent_ind":2,"word":"FDA","mention_type":"PROPER","token_ind":31,"end_ind":32},{"sent_ind":7,"word":"The FDA","mention_type":"PROPER","token_ind":1,"end_ind":3}],[{"sent_ind":14,"word":"Boehringer Ingelheim","mention_type":"PROPER","token_ind":1,"end_ind":3},{"sent_ind":2,"word":"it","mention_type":"PRONOMINAL","token_ind":17,"end_ind":18},{"sent_ind":2,"word":"German drug firm Boehringer Ingelheim","mention_type":"PROPER","token_ind":1,"end_ind":6},{"sent_ind":11,"word":"Boehringer Ingelheim","mention_type":"PROPER","token_ind":1,"end_ind":3}],[{"sent_ind":8,"word":"the administration","mention_type":"NOMINAL","token_ind":31,"end_ind":33},{"sent_ind":2,"word":"the US Food and Drug Administration","mention_type":"LIST","token_ind":24,"end_ind":30}],[{"sent_ind":3,"word":"the company 's","mention_type":"NOMINAL","token_ind":29,"end_ind":32},{"sent_ind":2,"word":"the company","mention_type":"NOMINAL","token_ind":34,"end_ind":36},{"sent_ind":14,"word":"the company","mention_type":"NOMINAL","token_ind":6,"end_ind":8}],[{"sent_ind":3,"word":"its","mention_type":"PRONOMINAL","token_ind":48,"end_ind":49},{"sent_ind":3,"word":"The response of the authorities and the complexity and extent of further questions that would need to be addressed to potentially obtain registration for flibanserin","mention_type":"NOMINAL","token_ind":2,"end_ind":27}],[{"sent_ind":15,"word":"The decision","mention_type":"NOMINAL","token_ind":2,"end_ind":4},{"sent_ind":3,"word":"the company 's decision to focus on other pipeline projects","mention_type":"NOMINAL","token_ind":29,"end_ind":39}],[{"sent_ind":6,"word":"flibanserin 's","mention_type":"NOMINAL","token_ind":5,"end_ind":7},{"sent_ind":4,"word":"the drug flibanserin -- in the form of a pink pill --","mention_type":"NOMINAL","token_ind":7,"end_ind":19}],[{"sent_ind":4,"word":"a potential libido aid","mention_type":"NOMINAL","token_ind":25,"end_ind":29},{"sent_ind":4,"word":"it","mention_type":"PRONOMINAL","token_ind":32,"end_ind":33}],[{"sent_ind":5,"word":"Lack of desire","mention_type":"NOMINAL","token_ind":1,"end_ind":4},{"sent_ind":5,"word":"the most common sexual problem in women aged 30 to 60","mention_type":"NOMINAL","token_ind":5,"end_ind":16}],[{"sent_ind":5,"word":"men in the same age bracket","mention_type":"NOMINAL","token_ind":28,"end_ind":34},{"sent_ind":11,"word":"men","mention_type":"NOMINAL","token_ind":22,"end_ind":23}],[{"sent_ind":6,"word":"the United States","mention_type":"PROPER","token_ind":24,"end_ind":27},{"sent_ind":7,"word":"US","mention_type":"PROPER","token_ind":8,"end_ind":9}],[{"sent_ind":14,"word":"women suffering with HSDD , a significant","mention_type":"NOMINAL","token_ind":19,"end_ind":26}],[{"sent_ind":14,"word":"many women","mention_type":"NOMINAL","token_ind":35,"end_ind":37}]],"text":[["German","firm","shelves","libido-boosting","drug","for","women","."],["German","drug","firm","Boehringer","Ingelheim","has","shelved","development","of","a","libido","-","booster","for","women","after","it","was","given","the","thumbs","down","by","the","US","Food","and","Drug","Administration","-LRB-","FDA","-RRB-",",","the","company","said","."],["``","The","response","of","the","authorities","and","the","complexity","and","extent","of","further","questions","that","would","need","to","be","addressed","to","potentially","obtain","registration","for","flibanserin","have","impacted","the","company","'s","decision","to","focus","on","other","pipeline","projects",",","''","Boehringer","said","in","the","statement","published","on","its","website","."],["Originally","intended","as","an","anti-depressant",",","the","drug","flibanserin","--","in","the","form","of","a","pink","pill","--","began","being","tested","years","ago","as","a","potential","libido","aid","after","women","said","it","failed","to","fight","the","blues","but","did","boost","their","sex","drive","."],["Lack","of","desire","is","the","most","common","sexual","problem","in","women","aged","30","to","60",",","just","as","erectile","dysfunction","is","the","most","common","sexual","disorder","among","men","in","the","same","age","bracket",",","researchers","said","."],["Clinical","trials","to","test","flibanserin","'s","efficacy","in","raising","the","level","of","sexual","desire","in","women","were","held","in","Canada",",","Europe","and","the","United","States","."],["The","FDA","said","in","June","that","two","US","trials","with","the","drug","and","a","placebo","``","both","failed","to","demonstrate","a","statistically","significant","improvement","on","the","co-primary","endpoint","of","sexual","desire",".","''"],["``","Therefore",",","neither","study","met","the","agreed-upon","criteria","for","success","in","establishing","the","efficacy","of","flibanserin","for","the","treatment","of","HSDD","-LRB-","hypoactive","sexual","desire","disorder","-RRB-",",","''","the","administration","added","."],["Besides","the","inconclusive","results",",","the","FDA","noted","the","drug","in","some","patients","caused","side","effects","including","depression","and","dizziness","."],["The","US","Reproductive","Health","Drugs","Advisory","Committee","also","said","that","the","efficacy","and","safety","of","flibanserin","had","not","been","determined","."],["Boehringer","Ingelheim","has","been","researching","flibanserin","as","a","treatment","for","post","-","menopausal","HSDD","in","women","since","the","popular","Viagra","for","men","hit","the","market","in","1998","."],["The","potential","market","for","a","libido","booster","for","women","has","been","estimated","by","some","analysts","at","around","two","billion","dollars","."],["Flibanserin","belongs","to","a","family","of","anti-depressants","that","acts","on","the","body","'s","level","of","serotonin",",","a","molecule","that","plays","a","role","in","mood","changes","."],["Boehringer","Ingelheim","said","that","``","the","company","continues","to","believe","in","the","value","that","flibanserin","would","have","for","women","suffering","with","HSDD",",","a","significant","and","recognised","medical","condition","which","impacts","the","lives","of","many","women","around","the","world",".","''"],["``","The","decision","was","not","made","lightly",",","considering","the","advanced","stage","of","development",",","''","board","chairman","Andreas","Barner","was","quoted","as","saying","."]],"part_of_speech":[["JJ","NN","NNS","JJ","NN","IN","NNS","."],["JJ","NN","NN","NNP","NNP","VBZ","VBN","NN","IN","DT","NN",":","NN","IN","NNS","IN","PRP","VBD","VBN","DT","NNS","RP","IN","DT","NNP","NNP","CC","NNP","NNP","-LRB-","NNP","-RRB-",",","DT","NN","VBD","."],["``","DT","NN","IN","DT","NNS","CC","DT","NN","CC","NN","IN","JJ","NNS","WDT","MD","VB","TO","VB","VBN","TO","RB","VB","NN","IN","NN","VBP","VBN","DT","NN","POS","NN","TO","VB","IN","JJ","NN","NNS",",","''","NNP","VBD","IN","DT","NN","VBN","IN","PRP$","NN","."],["RB","VBN","IN","DT","JJ",",","DT","NN","NN",":","IN","DT","NN","IN","DT","JJ","NN",":","VBD","VBG","VBN","NNS","RB","IN","DT","JJ","NN","NN","IN","NNS","VBD","PRP","VBD","TO","VB","DT","NNS","CC","VBD","VB","PRP$","NN","NN","."],["NN","IN","NN","VBZ","DT","RBS","JJ","JJ","NN","IN","NNS","JJ","CD","TO","CD",",","RB","IN","JJ","NN","VBZ","DT","RBS","JJ","JJ","NN","IN","NNS","IN","DT","JJ","NN","NN",",","NNS","VBD","."],["JJ","NNS","TO","VB","NN","POS","NN","IN","VBG","DT","NN","IN","JJ","NN","IN","NNS","VBD","VBN","IN","NNP",",","NNP","CC","DT","NNP","NNPS","."],["DT","NNP","VBD","IN","NNP","WDT","CD","NNP","NNS","IN","DT","NN","CC","DT","NN","``","CC","VBD","TO","VB","DT","RB","JJ","NN","IN","DT","JJ","NN","IN","JJ","NN",".","''"],["``","RB",",","CC","NN","VBD","DT","JJ","NNS","IN","NN","IN","VBG","DT","NN","IN","NN","IN","DT","NN","IN","NN","-LRB-","JJ","JJ","NN","NN","-RRB-",",","''","DT","NN","VBD","."],["IN","DT","JJ","NNS",",","DT","NNP","VBD","DT","NN","IN","DT","NNS","VBD","JJ","NNS","VBG","NN","CC","NN","."],["DT","NNP","NNP","NNP","NNPS","NNP","NNP","RB","VBD","IN","DT","NN","CC","NN","IN","NN","VBD","RB","VBN","VBN","."],["NNP","NNP","VBZ","VBN","VBG","NN","IN","DT","NN","IN","NN",":","JJ","NN","IN","NNS","IN","DT","JJ","NNP","IN","NNS","VBD","DT","NN","IN","CD","."],["DT","JJ","NN","IN","DT","NN","NN","IN","NNS","VBZ","VBN","VBN","IN","DT","NNS","IN","IN","CD","CD","NNS","."],["NN","VBZ","TO","DT","NN","IN","NNS","WDT","VBZ","IN","DT","NN","POS","NN","IN","NN",",","DT","NN","WDT","VBZ","DT","NN","IN","NN","NNS","."],["NNP","NNP","VBD","IN","``","DT","NN","VBZ","TO","VB","IN","DT","NN","WDT","NN","MD","VB","IN","NNS","VBG","IN","NN",",","DT","JJ","CC","VBD","JJ","NN","WDT","VBZ","DT","NNS","IN","JJ","NNS","IN","DT","NN",".","''"],["``","DT","NN","VBD","RB","VBN","RB",",","VBG","DT","JJ","NN","IN","NN",",","''","NN","NN","NNP","NNP","VBD","VBN","IN","VBG","."]],"totalParse":{"1":[[0,5,"root"],[3,1,"amod"],[3,2,"compound"],[5,3,"compound"],[5,4,"amod"],[5,7,"nmod$for"],[5,8,"punct"],[7,6,"case"]],"2":[[0,36,"root"],[35,34,"det"],[36,35,"nsubj"],[36,37,"punct"],[36,7,"ccomp"],[36,33,"punct"],[5,3,"compound"],[5,4,"compound"],[5,1,"amod"],[5,2,"compound"],[7,19,"advcl"],[7,5,"nsubj"],[7,6,"aux"],[7,8,"dobj"],[8,11,"nmod$of"],[11,9,"case"],[11,10,"det"],[11,12,"punct"],[11,13,"dep"],[13,15,"nmod$for"],[15,14,"case"],[19,21,"dobj"],[19,22,"compound:prt"],[19,26,"nmod$agent"],[19,29,"nmod$agent"],[19,16,"mark"],[19,17,"nsubjpass"],[19,18,"auxpass"],[21,20,"det"],[26,23,"case"],[26,24,"det"],[26,25,"compound"],[26,27,"cc"],[26,29,"conj$and"],[29,28,"compound"],[29,31,"appos"],[31,30,"punct"],[31,32,"punct"]],"3":[[0,42,"root"],[3,6,"nmod$of"],[3,7,"cc"],[3,9,"conj$and"],[3,11,"conj$and"],[3,2,"det"],[6,4,"case"],[6,5,"det"],[9,8,"det"],[9,10,"cc"],[9,11,"conj$and"],[9,14,"nmod$of"],[14,12,"case"],[14,13,"amod"],[14,15,"ref"],[14,17,"acl:relcl"],[17,14,"nsubj"],[17,16,"aux"],[17,20,"xcomp"],[20,23,"xcomp"],[20,14,"nsubjpass"],[20,18,"mark"],[20,19,"auxpass"],[23,22,"advmod"],[23,24,"dobj"],[23,14,"nsubj"],[23,21,"mark"],[24,26,"nmod$for"],[26,25,"case"],[28,9,"nsubj"],[28,27,"aux"],[28,32,"dobj"],[28,3,"nsubj"],[30,29,"det"],[30,31,"case"],[32,30,"nmod:poss"],[32,34,"acl"],[34,38,"nmod$on"],[34,33,"mark"],[38,35,"case"],[38,36,"amod"],[38,37,"compound"],[42,39,"punct"],[42,40,"punct"],[42,41,"nsubj"],[42,28,"ccomp"],[42,45,"nmod$in"],[42,1,"punct"],[42,50,"punct"],[45,43,"case"],[45,44,"det"],[45,46,"acl"],[46,49,"nmod$on"],[49,47,"case"],[49,48,"nmod:poss"]],"4":[[0,19,"root"],[43,41,"nmod:poss"],[43,42,"compound"],[2,1,"advmod"],[2,5,"nmod$as"],[5,3,"case"],[5,4,"det"],[9,13,"nmod$in"],[9,7,"det"],[9,8,"compound"],[13,10,"punct"],[13,11,"case"],[13,12,"det"],[13,17,"nmod$of"],[13,18,"punct"],[17,14,"case"],[17,15,"det"],[17,16,"amod"],[19,9,"nsubj"],[19,44,"punct"],[19,31,"dep"],[19,2,"ccomp"],[19,21,"xcomp"],[19,6,"punct"],[21,28,"nmod$as"],[21,20,"auxpass"],[21,23,"advmod"],[23,22,"nmod:npmod"],[28,25,"det"],[28,26,"amod"],[28,27,"compound"],[28,30,"nmod$after"],[28,24,"case"],[30,29,"case"],[31,33,"ccomp"],[31,40,"ccomp"],[33,32,"nsubj"],[33,35,"xcomp"],[33,38,"cc"],[33,40,"conj$but"],[35,32,"nsubj"],[35,34,"mark"],[35,37,"dobj"],[37,36,"det"],[40,43,"dobj"],[40,32,"nsubj"],[40,39,"aux"]],"5":[[0,36,"root"],[12,13,"dep"],[13,15,"nmod$to"],[15,14,"case"],[20,19,"amod"],[24,23,"advmod"],[26,28,"nmod$among"],[26,17,"advmod"],[26,33,"nmod$in"],[26,18,"mark"],[26,20,"nsubj"],[26,21,"cop"],[26,22,"det"],[26,24,"amod"],[26,25,"amod"],[28,27,"case"],[33,29,"case"],[33,30,"det"],[33,31,"amod"],[33,32,"compound"],[36,34,"punct"],[36,35,"nsubj"],[36,37,"punct"],[36,9,"ccomp"],[1,3,"nmod$of"],[3,2,"case"],[7,6,"advmod"],[9,1,"nsubj"],[9,4,"cop"],[9,5,"det"],[9,7,"amod"],[9,8,"amod"],[9,11,"nmod$in"],[11,12,"amod"],[11,16,"punct"],[11,10,"case"],[11,26,"acl"]],"6":[[0,18,"root"],[2,1,"amod"],[2,4,"acl"],[4,3,"mark"],[4,7,"dobj"],[4,9,"advcl"],[5,6,"case"],[7,5,"nmod:poss"],[9,16,"nmod$in"],[9,8,"mark"],[9,11,"dobj"],[11,10,"det"],[11,14,"nmod$of"],[14,12,"case"],[14,13,"amod"],[16,15,"case"],[18,17,"auxpass"],[18,2,"nsubjpass"],[18,20,"nmod$in"],[18,22,"nmod$in"],[18,26,"nmod$in"],[18,27,"punct"],[20,19,"case"],[20,21,"punct"],[20,22,"conj$and"],[20,23,"cc"],[20,26,"conj$and"],[26,24,"det"],[26,25,"compound"]],"7":[[0,3,"root"],[18,20,"xcomp"],[18,5,"dep"],[18,9,"nsubj"],[18,16,"punct"],[18,17,"nsubj"],[20,19,"mark"],[20,24,"dobj"],[20,9,"nsubj"],[20,17,"nsubj"],[23,22,"advmod"],[24,21,"det"],[24,23,"amod"],[24,28,"nmod$on"],[28,25,"case"],[28,26,"det"],[28,27,"amod"],[28,31,"nmod$of"],[31,29,"case"],[31,30,"amod"],[2,1,"det"],[3,2,"nsubj"],[3,5,"nmod$in"],[3,32,"punct"],[3,33,"punct"],[5,18,"acl:relcl"],[5,4,"case"],[5,6,"ref"],[9,7,"nummod"],[9,8,"compound"],[9,12,"nmod$with"],[9,15,"nmod$with"],[12,10,"case"],[12,11,"det"],[12,13,"cc"],[12,15,"conj$and"],[15,14,"det"]],"8":[[0,33,"root"],[5,4,"det"],[6,5,"nsubj"],[6,9,"dobj"],[6,29,"punct"],[6,30,"punct"],[6,1,"punct"],[6,2,"advmod"],[6,3,"punct"],[9,7,"det"],[9,8,"amod"],[9,11,"nmod$for"],[11,10,"case"],[11,13,"acl"],[13,12,"mark"],[13,15,"dobj"],[13,20,"nmod$for"],[15,14,"det"],[15,17,"nmod$of"],[17,16,"case"],[20,22,"nmod$of"],[20,18,"case"],[20,19,"det"],[22,21,"case"],[22,27,"appos"],[27,23,"punct"],[27,24,"amod"],[27,25,"amod"],[27,26,"compound"],[27,28,"punct"],[32,31,"det"],[33,6,"dep"],[33,32,"nsubj"],[33,34,"punct"]],"9":[[0,8,"root"],[4,1,"case"],[4,2,"det"],[4,3,"amod"],[7,6,"det"],[8,14,"ccomp"],[8,4,"nmod$besides"],[8,5,"punct"],[8,21,"punct"],[8,7,"nsubj"],[10,9,"det"],[10,13,"nmod$in"],[13,11,"case"],[13,12,"det"],[14,10,"nsubj"],[14,16,"dobj"],[16,15,"amod"],[16,18,"nmod$including"],[16,20,"nmod$including"],[18,17,"case"],[18,19,"cc"],[18,20,"conj$and"]],"10":[[0,9,"root"],[7,1,"det"],[7,2,"compound"],[7,3,"compound"],[7,4,"compound"],[7,5,"compound"],[7,6,"compound"],[9,20,"ccomp"],[9,21,"punct"],[9,7,"nsubj"],[9,8,"advmod"],[12,11,"det"],[12,13,"cc"],[12,14,"conj$and"],[12,16,"nmod$of"],[16,15,"case"],[20,12,"nsubjpass"],[20,14,"nsubjpass"],[20,17,"aux"],[20,18,"neg"],[20,19,"auxpass"],[20,10,"mark"]],"11":[[0,5,"root"],[2,1,"compound"],[5,2,"nsubj"],[5,3,"aux"],[5,4,"aux"],[5,6,"dobj"],[5,23,"ccomp"],[5,28,"punct"],[9,7,"case"],[9,8,"det"],[11,10,"case"],[11,12,"punct"],[14,16,"nmod$in"],[14,20,"nmod$since"],[14,13,"amod"],[16,15,"case"],[20,17,"case"],[20,18,"det"],[20,19,"amod"],[20,22,"nmod$for"],[22,21,"case"],[23,14,"nsubj"],[23,9,"nmod$as"],[23,25,"dobj"],[23,11,"nmod$for"],[23,27,"nmod$in"],[25,24,"det"],[27,26,"case"]],"12":[[0,12,"root"],[3,1,"det"],[3,2,"amod"],[3,7,"nmod$for"],[7,4,"case"],[7,5,"det"],[7,6,"compound"],[7,9,"nmod$for"],[9,8,"case"],[12,3,"nsubjpass"],[12,20,"nmod$at"],[12,21,"punct"],[12,10,"aux"],[12,11,"auxpass"],[12,15,"nmod$agent"],[15,13,"case"],[15,14,"det"],[19,17,"advmod"],[19,18,"compound"],[20,19,"nummod"],[20,16,"case"]],"13":[[0,2,"root"],[2,5,"nmod$to"],[2,27,"punct"],[2,1,"nsubj"],[2,17,"punct"],[2,19,"dobj"],[5,4,"det"],[5,7,"nmod$of"],[5,8,"ref"],[5,9,"acl:relcl"],[5,3,"case"],[7,6,"case"],[9,5,"nsubj"],[9,14,"nmod$on"],[12,11,"det"],[12,13,"case"],[14,10,"case"],[14,12,"nmod:poss"],[14,16,"nmod$of"],[16,15,"case"],[19,20,"ref"],[19,21,"acl:relcl"],[19,18,"det"],[21,23,"dobj"],[21,26,"nmod$in"],[21,19,"nsubj"],[23,22,"det"],[26,24,"case"],[26,25,"compound"]],"14":[[0,3,"root"],[7,6,"det"],[8,7,"nsubj"],[8,10,"xcomp"],[8,4,"mark"],[8,5,"punct"],[10,7,"nsubj"],[10,23,"punct"],[10,9,"mark"],[10,13,"nmod$in"],[10,29,"dobj"],[13,11,"case"],[13,12,"det"],[13,14,"ref"],[13,17,"acl:relcl"],[17,13,"dobj"],[17,15,"nsubj"],[17,16,"aux"],[17,19,"nmod$for"],[19,18,"case"],[19,20,"acl"],[20,22,"nmod$with"],[22,21,"case"],[25,26,"cc"],[25,27,"conj$and"],[29,24,"det"],[29,25,"amod"],[29,27,"amod"],[29,28,"amod"],[29,30,"ref"],[29,31,"acl:relcl"],[31,39,"nmod$around"],[31,29,"nsubj"],[31,33,"dobj"],[33,32,"det"],[33,36,"nmod$of"],[36,34,"case"],[36,35,"amod"],[39,37,"case"],[39,38,"det"],[2,1,"compound"],[3,8,"ccomp"],[3,40,"punct"],[3,41,"punct"],[3,2,"nsubj"]],"15":[[0,22,"root"],[3,2,"det"],[6,3,"nsubjpass"],[6,4,"auxpass"],[6,5,"neg"],[6,7,"advmod"],[6,8,"punct"],[6,9,"xcomp"],[9,12,"dobj"],[12,10,"det"],[12,11,"amod"],[12,14,"nmod$of"],[14,13,"case"],[20,17,"compound"],[20,18,"compound"],[20,19,"compound"],[22,15,"punct"],[22,16,"punct"],[22,1,"punct"],[22,20,"nsubjpass"],[22,21,"auxpass"],[22,6,"ccomp"],[22,24,"advcl"],[22,25,"punct"],[24,23,"mark"]]},"processed":{"1":[],"2":[{"edgeName":"nsubj","govWord":"shelved , said .","depWord":"the company","dep":[34,35],"gov":[7,33,36,37]},{"edgeName":"nsubj","govWord":"has shelved development given","depWord":"German drug firm Boehringer Ingelheim","dep":[1,2,3,4,5],"gov":[6,7,8,19]},{"edgeName":"dobj","govWord":"Ingelheim has shelved given","depWord":"development libido","dep":[8,11],"gov":[5,6,7,19]},{"edgeName":"dobj","govWord":"after it was given down Food Administration","depWord":"the thumbs","dep":[20,21],"gov":[16,17,18,19,22,26,29]},{"edgeName":"nsubjpass","govWord":"after was given thumbs down Food Administration","depWord":"it","dep":[17],"gov":[16,18,19,21,22,26,29]},{"edgeName":"appos","govWord":"Drug Administration","depWord":"-LRB- FDA -RRB-","dep":[30,31,32],"gov":[28,29]}],"3":[{"edgeName":"nsubj","govWord":"would need addressed","depWord":"of further questions that","dep":[12,13,14,15],"gov":[16,17,20]},{"edgeName":"nsubjpass","govWord":"to be addressed obtain","depWord":"of further questions that need","dep":[12,13,14,15,17],"gov":[18,19,20,23]},{"edgeName":"dobj","govWord":"questions to potentially obtain","depWord":"registration flibanserin","dep":[24,26],"gov":[14,21,22,23]},{"edgeName":"nsubj","govWord":"to potentially obtain registration","depWord":"of further questions that need","dep":[12,13,14,15,17],"gov":[21,22,23,24]},{"edgeName":"nsubj","govWord":"response have impacted decision","depWord":"the complexity and extent questions","dep":[8,9,10,11,14],"gov":[3,27,28,32]},{"edgeName":"dobj","govWord":"response complexity have impacted","depWord":"company decision focus","dep":[30,32,34],"gov":[3,9,27,28]},{"edgeName":"nsubj","govWord":"complexity have impacted decision","depWord":"The response authorities and complexity extent","dep":[2,3,6,7,9,11],"gov":[9,27,28,32]},{"edgeName":"nsubj","govWord":"`` impacted , '' said statement .","depWord":"Boehringer","dep":[41],"gov":[1,28,39,40,42,45,50]}],"4":[{"edgeName":"nsubj","govWord":"intended , began tested said .","depWord":"the drug flibanserin form","dep":[7,8,9,13],"gov":[2,6,19,21,31,44]},{"edgeName":"nsubj","govWord":"failed fight but boost","depWord":"it","dep":[32],"gov":[33,35,38,40]},{"edgeName":"nsubj","govWord":"to fight blues","depWord":"it","dep":[32],"gov":[34,35,37]},{"edgeName":"dobj","govWord":"it to fight","depWord":"the blues","dep":[36,37],"gov":[32,34,35]},{"edgeName":"dobj","govWord":"it did boost","depWord":"their sex drive","dep":[41,42,43],"gov":[32,39,40]},{"edgeName":"nsubj","govWord":"did boost drive","depWord":"it","dep":[32],"gov":[39,40,43]}],"5":[{"edgeName":"nsubj","govWord":"just as is the common sexual disorder men bracket","depWord":"erectile dysfunction","dep":[19,20],"gov":[17,18,21,22,24,25,26,28,33]},{"edgeName":"nsubj","govWord":"problem , said .","depWord":"researchers","dep":[35],"gov":[9,34,36,37]},{"edgeName":"nsubj","govWord":"is the common sexual problem women","depWord":"Lack desire","dep":[1,3],"gov":[4,5,7,8,9,11]}],"6":[{"edgeName":"dobj","govWord":"to test raising","depWord":"flibanserin efficacy","dep":[5,7],"gov":[3,4,9]},{"edgeName":"dobj","govWord":"in raising women","depWord":"the level desire","dep":[10,11,14],"gov":[8,9,16]},{"edgeName":"nsubjpass","govWord":"were held Canada Europe States .","depWord":"Clinical trials test","dep":[1,2,4],"gov":[17,18,20,22,26,27]}],"7":[{"edgeName":"nsubj","govWord":"June `` both failed demonstrate","depWord":"two US trials drug placebo","dep":[7,8,9,12,15],"gov":[5,16,17,18,20]},{"edgeName":"nsubj","govWord":"June trials `` failed demonstrate","depWord":"both","dep":[17],"gov":[5,9,16,18,20]},{"edgeName":"dobj","govWord":"trials both to demonstrate","depWord":"a significant improvement endpoint","dep":[21,23,24,28],"gov":[9,17,19,20]},{"edgeName":"nsubj","govWord":"both to demonstrate improvement","depWord":"two US trials drug placebo","dep":[7,8,9,12,15],"gov":[17,19,20,24]},{"edgeName":"nsubj","govWord":"trials to demonstrate improvement","depWord":"both","dep":[17],"gov":[9,19,20,24]},{"edgeName":"nsubj","govWord":"said June . ''","depWord":"The FDA","dep":[1,2],"gov":[3,5,32,33]}],"8":[{"edgeName":"nsubj","govWord":"`` Therefore , met criteria , ''","depWord":"neither study","dep":[4,5],"gov":[1,2,3,6,9,29,30]},{"edgeName":"dobj","govWord":"`` Therefore , study met , ''","depWord":"the agreed-upon criteria success","dep":[7,8,9,11],"gov":[1,2,3,5,6,29,30]},{"edgeName":"dobj","govWord":"in establishing treatment","depWord":"the efficacy flibanserin","dep":[14,15,17],"gov":[12,13,20]},{"edgeName":"appos","govWord":"of HSDD","depWord":"-LRB- hypoactive sexual desire disorder -RRB-","dep":[23,24,25,26,27,28],"gov":[21,22]},{"edgeName":"nsubj","govWord":"met added .","depWord":"the administration","dep":[31,32],"gov":[6,33,34]}],"9":[{"edgeName":"nsubj","govWord":"results , noted caused .","depWord":"the FDA","dep":[6,7],"gov":[4,5,8,14,21]},{"edgeName":"nsubj","govWord":"caused effects","depWord":"the drug patients","dep":[9,10,13],"gov":[14,16]},{"edgeName":"dobj","govWord":"drug caused","depWord":"side effects depression dizziness","dep":[15,16,18,20],"gov":[10,14]}],"10":[{"edgeName":"nsubj","govWord":"also said determined .","depWord":"The US Reproductive Health Drugs Advisory Committee","dep":[1,2,3,4,5,6,7],"gov":[8,9,20,21]},{"edgeName":"nsubjpass","govWord":"that safety had not been determined","depWord":"the efficacy and safety flibanserin","dep":[11,12,13,14,16],"gov":[10,14,17,18,19,20]},{"edgeName":"nsubjpass","govWord":"that efficacy had not been determined","depWord":"safety","dep":[14],"gov":[10,12,17,18,19,20]}],"11":[{"edgeName":"nsubj","govWord":"has been researching flibanserin hit .","depWord":"Boehringer Ingelheim","dep":[1,2],"gov":[3,4,5,6,23,28]},{"edgeName":"dobj","govWord":"Ingelheim has been researching hit .","depWord":"flibanserin","dep":[6],"gov":[2,3,4,5,23,28]},{"edgeName":"nsubj","govWord":"treatment post hit market 1998","depWord":"menopausal HSDD women Viagra","dep":[13,14,16,20],"gov":[9,11,23,25,27]},{"edgeName":"dobj","govWord":"treatment post HSDD hit 1998","depWord":"the market","dep":[24,25],"gov":[9,11,14,23,27]}],"12":[{"edgeName":"nsubjpass","govWord":"has been estimated analysts dollars .","depWord":"The potential market booster","dep":[1,2,3,7],"gov":[10,11,12,15,20,21]}],"13":[{"edgeName":"nsubj","govWord":"belongs family , molecule .","depWord":"Flibanserin","dep":[1],"gov":[2,5,17,19,27]},{"edgeName":"dobj","govWord":"Flibanserin belongs family , .","depWord":"a molecule that plays","dep":[18,19,20,21],"gov":[1,2,5,17,27]},{"edgeName":"nsubj","govWord":"acts level","depWord":"to a family anti-depressants that","dep":[3,4,5,7,8],"gov":[9,14]},{"edgeName":"dobj","govWord":"molecule plays changes","depWord":"a role","dep":[22,23],"gov":[19,21,26]},{"edgeName":"nsubj","govWord":"plays role changes","depWord":"a molecule that","dep":[18,19,20],"gov":[21,23,26]}],"14":[{"edgeName":"nsubj","govWord":"that `` continues believe","depWord":"the company","dep":[6,7],"gov":[4,5,8,10]},{"edgeName":"nsubj","govWord":"to believe value , condition","depWord":"the company","dep":[6,7],"gov":[9,10,13,23,29]},{"edgeName":"dobj","govWord":"company to believe value ,","depWord":"a significant recognised medical condition which impacts","dep":[24,25,27,28,29,30,31],"gov":[7,9,10,13,23]},{"edgeName":"dobj","govWord":"flibanserin would have women","depWord":"in the value that","dep":[11,12,13,14],"gov":[15,16,17,19]},{"edgeName":"nsubj","govWord":"value would have women","depWord":"flibanserin","dep":[15],"gov":[13,16,17,19]},{"edgeName":"nsubj","govWord":"impacts lives world","depWord":"a significant recognised medical condition which","dep":[24,25,27,28,29,30],"gov":[31,33,39]},{"edgeName":"dobj","govWord":"condition impacts world","depWord":"the lives women","dep":[32,33,36],"gov":[29,31,39]},{"edgeName":"nsubj","govWord":"said continues . ''","depWord":"Boehringer Ingelheim","dep":[1,2],"gov":[3,8,40,41]}],"15":[{"edgeName":"nsubjpass","govWord":"was not made lightly , considering","depWord":"The decision","dep":[2,3],"gov":[4,5,6,7,8,9]},{"edgeName":"dobj","govWord":"considering","depWord":"the advanced stage development","dep":[10,11,12,14],"gov":[9]},{"edgeName":"nsubjpass","govWord":"`` made , '' was quoted saying .","depWord":"board chairman Andreas Barner","dep":[17,18,19,20],"gov":[1,6,15,16,21,22,24,25]}]}}